We are delighted to announce that three excellent faculty from the Department of Biomedical Science have joined the Milwaukee Institute for Drug Discovery. Professor Janis Eells (left) is a pharmacologist with an appointment as Adjunct Professor at the Medical College… Read More
UWM’s STAR program seeks to help fill that gap by preparing students from underrepresented backgrounds for graduate training and careers in aging and public health. The UWM STAR program is a multi-year, cohort-based program that matches students from underrepresented backgrounds… Read More
We are delighted to announce two new MIDD members: Arjun Saha, Assistant Professor from the Department of Chemistry and Biochemistry investigates the development and application of novel computational chemistry and biophysics approaches to gain fundamental understanding of remarkable biological processes… Read More
The MIDD has welcomed Steve Weitman as new member. Dr. Weitman was the AT&T Distinguished Chair for Drug Development at the University of Texas Health Science Center at San Antonio and is currently enjoying his retirement in Wisconsin. He obtained… Read More
The MIDD Symposium will bring together UWM faculty members, students and followers supporting interdisciplinary research in Drug Discovery. This is a in-person and online event. This year we invited speakers from our industry partners and startup companies located at UWM…. Read More
Graduate Student Taufeeque Ali has been selected by MIDD members based on scientific merit and potential to accelerate the development of Novel Combination Strategies for Tumor-Selective Activation of ROS-Activated DNA Cross-Linking Agents. Together with undergraduate students Dhivyashree Senthil Murugan, Alexis… Read More
We are thrilled to share that Estrigenix Therapeutics has been awarded a phase 1 SBIR grant from the National Institute of Health. The one-year grant provides funds to support pre-clinical studies on one of Estrigenix’s lead compounds to reduce women’s… Read More
The Ramsay Research Grant, awarded by Solve M.E. Foundation, supports research to understand the underlying causes of ME/CFS and Long Covid. Dr. Avik Roy has received this Award in 2022. He is part of Simmaron’s new research team, which moved… Read More
Pantherics Incorporated, a UWM startup company received a $255,841 Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute, to advance development of a fundamentally novel anti-inflammatory drug, with… Read More
The UWM Research Foundation has awarded “Bradley Catalyst” funding to Prof. Frick to evaluate new lead compound EGX854, which has demonstrated greater selectivity and 4-fold better potency. EGX854 has also shown potential for better brain penetration. Dr. Frick will evaluate… Read More